Neurim fights to amend Circadin patent amid infringement case against generics
Intellectual Property November 12, 2018 9:19 pm By Miklos Bolza | Sydney

Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.